首页> 外文期刊>International journal of molecular medicine >Overlapping molecular pathways between cannabinoid receptors type 1 and 2 and estrogens/androgens on the periphery and their involvement in the pathogenesis of common diseases (Review)
【24h】

Overlapping molecular pathways between cannabinoid receptors type 1 and 2 and estrogens/androgens on the periphery and their involvement in the pathogenesis of common diseases (Review)

机译:1型和2型大麻素受体与周围雌激素/雄激素之间的重叠分子途径及其与常见疾病发病机制的关系(综述)

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

The physiological and pathophysiological roles of sex hormones have been well documented and the modulation of their effects is applicable in many current treatments. On the other hand, the physiological role of endocannabinoids is not yet clearly understood and the endocannabinoid system is considered a relatively new therapeutic target. The physiological association between sex hormones and cannabinoids has been investigated in several studies; however, its involvement in the pathophysiology of common human diseases has been studied separately. Herein, we present the first systematic review of molecular pathways that are influenced by both the cannabinoids and sex hormones, including adenylate cyclase and protein kinase A, epidermal growth factor receptor, cyclic adenosine monophosphate response element-binding protein, vascular endothelial growth factor, proto-oncogene serine/threonine-protein kinase, mitogen-activated protein kinase, phosphatidylinosito1-4,5-bisphosphate 3-kinase, C-Jun N-terminal kinase and extracellular-signal-regulated kinases 1/2. Most of these influence cell proliferative activity. Better insight into this association may prove to be beneficial for the development of novel pharmacological treatment strategies for many common diseases, including breast cancer, endometrial cancer, prostate cancer, osteoporosis and atherosclerosis. The associations between cannabinoids, estrogens and androgens under these conditions are also presented and the molecular interactions are highlighted.
机译:性激素的生理和病理生理作用已得到充分证明,其作用的调节可用于许多目前的治疗中。另一方面,尚不清楚内源性大麻素的生理作用,并且内源性大麻素系统被认为是相对较新的治疗靶标。性激素和大麻素之间的生理联系已在几项研究中进行了研究。然而,其与人类常见疾病的病理生理学的关系已被单独研究。在本文中,我们首次对受大麻素和性激素(包括腺苷酸环化酶和蛋白激酶A,表皮生长因子受体,环状腺苷单磷酸反应元件结合蛋白,血管内皮生长因子,原-癌基因丝氨酸/苏氨酸蛋白激酶,促分裂原活化蛋白激酶,磷脂酰肌醇1-4,5-二磷酸3-激酶,C-Jun N端激酶和细胞外信号调节激酶1/2。这些大多数影响细胞增殖活性。更好地了解这种关联可能被证明有助于开发许多常见疾病的新型药物治疗策略,包括乳腺癌,子宫内膜癌,前列腺癌,骨质疏松症和动脉粥样硬化。还介绍了在这些条件下大麻素,雌激素和雄激素之间的缔合,并突出了分子间的相互作用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号